MedTrace Logo

Comparison of Slow Efficiency Daily Dialysis (SLEDD) With Unfractionated Heparin Versus Citrasate in Critically Ill Patients.

NCT01228292 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2010-10-26

No results posted yet for this study

Summary

The purpose of this study is to compare the feasibility, safety and efficacy of hemodialysis with unfractionated heparin compared to hemodialysis with Citrasate in Critically Ill Patients.

Conditions

Interventions

DRUG

Unfractionated heparin

dose 5-10 IU/kg/hrs adaptations of infusion rate upon APTT measurements during hemodialysis

DRUG

Citrasate

Citrasate is infused as a dialysate

Sponsors & Collaborators

  • University Hospital, Antwerp

    lead OTHER

Principal Investigators

  • Karin Jansen-Van doorn, MD · Staff member Nephrology Department

  • Gert Verpooten, PhD, MD · Head of Nephrology Department, University Hospital Antwerp, Belgium

  • Walter Verbrugghe, MD · Staff member Critical Care Department, Antwerp University Hospital, Belgium

  • Philippe Jorens, PhD, MD · Head of Critical Care Department, Antwerp University Hospital, Belgium

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-01-31
Completion
2013-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01228292 on ClinicalTrials.gov